Extracellular Hsp90 (eHsp90) as the Actual Target in Clinical Trials: Intentionally or Unintentionally

Despite extensive investigative studies and clinical trials over the past two decades, we still do not understand why cancer cells are more sensitive to the cellular toxicity of Hsp90 inhibitors than normal cells. We still do not understand why only some cancer cells are sensitive to the Hsp90 inhib...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Li, Wei, Tsen, Fred, Sahu, Divya, Bhatia, Ayesha, Chen, Mei, Multhoff, Gabriele, Woodley, David T.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4023563/
https://ncbi.nlm.nih.gov/pubmed/23445811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/B978-0-12-407697-6.00005-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky